Results 121 to 130 of about 47,577 (187)

Extent of resection and perioperative neurological status as prognostic markers in glioblastoma: a population-based study. [PDF]

J Neurooncol
Mendoza Mireles EE, Blakstad H, Server A, Leske H, Skaga E, Aarhus M, Brandal P, Helseth E, Nayak L, Rønning PA, Vik-Mo EO.   +10 more
europepmc   +1 more source

Feasibility and Safety of Autologous Dendritic Cell Vaccination Combined with Radio-Chemotherapy in Newly Diagnosed Glioblastoma: A Retrospective Single-Center Series. [PDF]

Vaccines (Basel)
Esparragosa Vázquez I, López-Díaz de Cerio A, Inoges S, Aristu J, Domínguez P, García-Eulate R, Calvo-Imirizaldu M, Arbizu J, Rodríguez-Ruiz ME, Irimia P, Alonso MM, Prósper F, Díez-Valle R, Gállego Pérez-Larraya J.   +13 more
europepmc   +1 more source

Glioblastoma survival in rural America: a 10-year experience from a quaternary care center. [PDF]

J Neurooncol
Pack E, Cifarelli CP, Bhatia S, Lewis J, Brandmeir N, Gleckman A, Han PC, Wages NA, Dotson TS, Denney MW, Wen S, Armistead M, Norouzi S, Aulakh S.   +13 more
europepmc   +1 more source

Isorhamnetin from Astragalus membranaceus exerts anti-glioma effects via PI3K/Akt signaling pathway. [PDF]

Am J Cancer Res
Luo M, Liu K, Wang Z, Li X, Wu C, Hao M, Pan Y, Zhang H, Wang Q.   +8 more
europepmc   +1 more source

A Positive Feedback DNA-PK/MYT1L-CXCR1-ERK1/2 Proliferative Signaling Loop in Glioblastoma. [PDF]

Int J Mol Sci
Wang B, Li D, Ilnytskyy Y, Khachigian LM, Zhong N, Rodriguez-Juarez R, Kovalchuk I, Kovalchuk O.   +7 more
europepmc   +1 more source

Targeting Metabolic Vulnerabilities in Glioblastoma: a Framework for Multi-node Combination Therapy. [PDF]

Curr Oncol Rep
Gokani V, Kotta A, Repaka V, Rauniyar S, Noch EK.   +4 more
europepmc   +1 more source

Next-generation immunotherapy biologics for glioblastoma. [PDF]

Front Immunol
Schonfeld E, Sjoholm A, Ha J, Liu J, Nageeb G, Annagiri S, Kim L, Choi J, Lim M.   +8 more
europepmc   +1 more source

miR-181d coordinates homologous recombination and anti-tumor immune responses in glioblastoma. [PDF]

iScience
Singh G, Singh S, Mohapatra I, Hou J, Ni A, Barik D, Zheng H, Kim S, Sharma M, Lawler S, Vasudevan S, Kokkoli E, Sarangi S, Elinzano H, Wong ET, Martinez-Moreno M, Gokaslan Z, El-Deiry W, Chen CC.   +18 more
europepmc   +1 more source

Mitochondrial connexin 43 modulates metabolic stress adaptation in glioma cell lines. [PDF]

Cell Commun Signal
Gervasi A, Denaro S, D'Aprile S, Potokar M, Jorgačevski J, Zorec R, Tibullo D, Zappalà A, Amorini AM, Parenti R, Vicario N.   +10 more
europepmc   +1 more source

Emerging insights into the immunosuppressive tumor microenvironment and its implications for glioblastoma immunotherapy. [PDF]

Front Immunol
Nicolaou N, Andreou MS, Neophytou CM, Papageorgis P.   +3 more
europepmc   +1 more source